METASTASIS is a phenomenon consisting of many steps, including release of cells from the tumour, circulation of released cells and their lodging at distant sites, and growth where these new sites are favourable. Both tumour-cell and host factors could be involved and interact in all these steps (Zeidman, 1957; Rubin & Green, 1968; Thompson, 1976) . Metastatic foci are formed at low frequency in spite of the release of many malignant cells into the circulation (Engel, 1959; Roberts et al., 1961) or despite i.v. injection of many living cells (Iwasaki, 1915;  Takahashi, 1915; Warren & Davis, 1934 .) Our working hypothesis to help explain this inefficiency of metastasis has been as follows: tumours vary with respect to their karyotype or malignant characteristic (Makino, 1957; Foulds, 1969; Nowell, 1976) so that cells within a tumour may be heterogeneous in various characteristics including malignant properties. Metastasis may require properties other than local growth ability, and variants with different potentials for metastatic growth may evolve during tumour development and progression. For metastatic growth, variants must meet the requirements for both dissemination and growth in the new tissue environment. Thus, metastasis could involve selective cloning. We have isolated clones from a mouse fibrosarcoma and characterized some of their cell charac- FSA 1233 is one of the clones isolated from a mouse fibrosarcoma (Suzuki & Withers, 1978a) and, after 5 subcultures, has been kept in liquid N2. The cells were cultured in McCoy's 5A medium as modified by Hsu, containing 20% foetal calf serum. Cell suspensions from secondary lung nodules or subcutaneous tumours were made 25 days after injection, using trypsin and DNase I (Suzuki & Withers, 1978a) . These cells were grown in culture for 10-20 days (3 subcultures) prior to i.v. injection into the tail veins of mice. No significant normal-cell contamination was observed by flow microfluorometry after this period of culture.
LCFE is affected by several factors: cellcycle stage (Suzuki et al., 1977a ) the in vitro growth conditions prior to i.v. inoculation (Bosmann & Lione, 1974 ) and (Suzuki et al., 1977a; Suzuki et al., 1978b Table.) parental FSA 1233, despite the 10-fold greater artificial lung-colony-forming ability of the LM1 cells. This indicates that some factors responsible for lungcolony formation are different from those involved in local subcutaneous growth. The present experimental results agree with various clinical and experimental facts: the inefficiency of metastasis formation despite the presence of many malignant cells in the blood stream (Engel, 1959; Roberts et al., 1961) tumour-specific distribution of metastatic foci, the "seed soil theory" of Paget (1889) , and the development concept of malignancy which suggests heterogeneity of karyotype or malignant characteristics among cells in a tumour (Makino, 1957; Foulds, 1969; Nowell, 1976) . Fidler (1973) has already isolated highly metastatic variants of B16 melanoma cells by 5 to 10 passages of the cells as lung metastases. B16 melanoma is a long-established line, whereas the clone used in these experiments was freshly isolated from a mouse fibrosarcoma. Our experiment showed that the selection of increased metastatic efficiency was specific to the organ in which the metastases were passaged, because s.c. passage did not enhance lung-colony-forming efficiency.
In summary, lung-colony formation was a selective cloning process for factors involved in lung-colony formation.
